Cboe UK CHF
Cosmo Pharmaceuticals N.V. (COPNZ.XC)
48.45
+0.55
+(1.15%)
As of 1:20:45 PM GMT+1. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
162.41M
162.41M
22.71M
33.23M
12.61M
Investing Cash Flow
-128.88M
-128.88M
53.22M
1.69M
24.86M
Financing Cash Flow
-40.22M
-40.22M
-211.27M
-46.13M
-27.25M
End Cash Position
44.30M
44.30M
50.27M
185.82M
198.56M
Capital Expenditure
-5.65M
-5.65M
-4.40M
-7.31M
-8.50M
Issuance of Capital Stock
3.38M
3.38M
687.00k
270.00k
761.00k
Repayment of Debt
-1.08M
-1.08M
-176.03M
-916.00k
-2.62M
Repurchase of Capital Stock
-5.93M
-5.93M
-12.47M
-24.75M
-20.51M
Free Cash Flow
156.76M
156.76M
18.31M
25.92M
4.11M
12/31/2021 - 11/5/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade